Elekta h
as introduced new intra-fraction imaging capabilities within its X-ray Volume Imaging (XVI) system. During treatment, XVI now provides the tools to monitor and manage internal motion, supporting the clinician’s efforts to increase therapeutic doses delivered to the tumor while reducing healthy tissue exposure. “Regardless of patient immobilization, both the tumor and adjacent critical structures may move during treatment delivery. Historically, this has presented a significant challenge in delivering highly targeted treatments,” says Dee Mathieson, Senior Vice President, ”On a second by second basis, the precise location of the tumor and sensitive healthy structures can now be visualized, thus helping clinicians accurately deliver dose to the tumor while minimizing normal tissue exposure. ”
Elekta
Stockholm, Sweden,